Position in ESPR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$0
+$0 QoQ
Shares Held
49,712
-47.2% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AXQ CAPITAL, LP holds $9,179,081 across 16 Drug Manufacturers - Specialty & Generic names. ESPR ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
41,355 | $2,971,770 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
50,448 | $1,241,525 | |
| 3 | VTRS |
Viatris Inc
|
76,086 | $1,208,245 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
23,376 | $959,117 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
12,095 | $571,730 | |
| 6 | LQDA |
Liquidia Corp
|
6,846 | $545,831 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
54,534 | $545,340 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
9,572 | $242,841 |
All Filings in ESPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 49,712 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | — | 94,159 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | — | 38,930 | Shares | Sole | 2025-11-10 | |
| 2022-12-31 | — | 48,061 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||